Stochastic Oscillator Analysis for CorMedix, Inc. (NYSE:CRMD)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of CorMedix, Inc. (NYSE:CRMD) for the period of 9-Day stands at 62.26% while the stochastic %D for the same period stands at 66.99%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of CorMedix, Inc. (NYSE:CRMD) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for CorMedix, Inc. (NYSE:CRMD) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently CorMedix, Inc. (NYSE:CRMD)’s 20-Day Bollinger Band indicates “Hold”.

About Company

CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications. The Company’s therapeutic candidates for cardiorenal disease may be small molecules, biologicals, devices and/or diagnostics (tests) that enable therapy. Its product pipeline includes: CRMD001, a unique formulation Deferiprone which is in development to prevent Contrast-Induced Acute Kidney Injury and to slow progression of Chronic Kidney Disease; CRMD002, a diagnostic test for urinary labile iron; CRMD003 (Neutrolin®, an antimicrobial/anticoagulant solution) is in development to prevent Catheter Related Bloodstream Infection; CRMD004, a pressure sensitive gel which has many uses, including extending the benefits of Neutrolin®. CorMedix Inc. is based in Summit, New Jersey.

Previous Day Activity Analysis

On the last trading day, CorMedix, Inc. (NYSE:CRMD) opened the session at $0.67 and after going down -5.97% closed at $0.64. The stock lost -0.03 points in the last trade.

CorMedix, Inc. (NYSE:CRMD)’s stock fluctuated in the range of $0.630 and $0.690 during the previous active session. CorMedix, Inc. (NYSE:CRMD) traded with the volume of 1.75 Million with average volume of 1.2 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 0.51 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.06 and 58.88 respectively.

Currently the Insider Ownership of the shares of CorMedix, Inc. (NYSE:CRMD) is at 5.1% and the shares outstanding are 64.89 Million.

Important Ratio Analysis

Some important ratios to consider here for CorMedix, Inc. (NYSE:CRMD) are discussed below:

Dividend yield of CorMedix, Inc. (NYSE:CRMD) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 138.04 and 2.36 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 3 and 0 correspondingly.

The Quick Ratio of CorMedix, Inc. (NYSE:CRMD) stands at 3.8 while the Current Ratio depicts the value of 3.8.

Return on Assets ROA of CorMedix, Inc. (NYSE:CRMD) is at -101.3% whereas, Return on Equity ROE and Return of Investment ROI of CorMedix, Inc. (NYSE:CRMD) stand at -121.6% and 0% respectively.

Stock Performance Analysis

The stock performance of CorMedix, Inc. (NYSE:CRMD) on the basis of 5 day trade show the jump of 4.11% whereas, the monthly performance of the stock shows increase of 58.76%.

The quarterly performance of the stock remained in green zone with the value of 63.64% while six month performance of the shares of CorMedix, Inc. (NYSE:CRMD) remained bearish with the count of -48.53%.

The yearly and YTD performance of CorMedix, Inc. (NYSE:CRMD) remained down at -74.87% and -58.29% respectively.